Literature DB >> 17291231

Consumption of black tea or coffee and risk of ovarian cancer.

J A Baker1, K Boakye, S E McCann, G P Beehler, K J Rodabaugh, J A Villella, K B Moysich.   

Abstract

The goal of this study was to investigate the associations between ovarian cancer risk and usual consumption of black tea, regular coffee, or decaffeinated coffee. Using a hospital-based case-control design, participants included 414 women with primary epithelial ovarian, fallopian, or peritoneal cancer and 868 age- and region-matched women with nonneoplastic conditions. All participants completed a comprehensive epidemiologic questionnaire. Black tea consumption was associated with a linear decline in ovarian cancer risk (P for trend 0.03), with individuals consuming two or more cups daily experiencing a 30% decline in risk (adjusted OR 0.70, 95% CI 0.51-0.97). Similar declines were noted among individuals consuming two or more cups of decaffeinated coffee daily (adjusted OR 0.71, 95% CI 0.51-0.99; P for trend 0.002). However, no association was noted between any level of regular coffee consumption and risk of ovarian cancer. The chemoprotective effects of phytochemicals in black tea and decaffeinated coffee may be important, although the effects of phytochemicals in regular coffee may be counteracted by the elevated risk associated with its higher caffeine content.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17291231     DOI: 10.1111/j.1525-1438.2006.00773.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  12 in total

Review 1.  Tea and health: preventive and therapeutic usefulness in the elderly?

Authors:  Bradley W Bolling; Chung-Yen Oliver Chen; Jeffrey B Blumberg
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

2.  Inhibitory Effects of the Four Main Theaflavin Derivatives Found in Black Tea on Ovarian Cancer Cells.

Authors:  Ying Gao; Gary O Rankin; Youying Tu; Yi Charlie Chen
Journal:  Anticancer Res       Date:  2016-02       Impact factor: 2.480

Review 3.  Green and black tea in relation to gynecologic cancers.

Authors:  Lesley M Butler; Anna H Wu
Journal:  Mol Nutr Food Res       Date:  2011-05-19       Impact factor: 5.914

4.  Coffee and caffeine intake and the risk of ovarian cancer: the Iowa Women's Health Study.

Authors:  Natalie A Lueth; Kristin E Anderson; Lisa J Harnack; Jayne A Fulkerson; Kim Robien
Journal:  Cancer Causes Control       Date:  2008-08-14       Impact factor: 2.506

5.  Flavonoid intake and ovarian cancer risk in a population-based case-control study.

Authors:  Margaret A Gates; Allison F Vitonis; Shelley S Tworoger; Bernard Rosner; Linda Titus-Ernstoff; Susan E Hankinson; Daniel W Cramer
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

6.  Synergistic effect of black tea polyphenol, theaflavin-3,3'-digallate with cisplatin against cisplatin resistant human ovarian cancer cells.

Authors:  Haibo Pan; Jin Li; Gary O Rankin; Yon Rojanasakul; Youying Tu; Yi Charlie Chen
Journal:  J Funct Foods       Date:  2018-04-26       Impact factor: 4.451

7.  Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53.

Authors:  Jasmine George; Madhulika Singh; Amit Kumar Srivastava; Kulpreet Bhui; Preeti Roy; Pranav Kumar Chaturvedi; Yogeshwer Shukla
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

8.  Tea consumption and the risk of ovarian cancer: A meta-analysis of epidemiological studies.

Authors:  Xin Zhan; Jie Wang; Shufen Pan; Caijuan Lu
Journal:  Oncotarget       Date:  2017-06-06

9.  Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis.

Authors:  J Steevens; L J Schouten; B A J Verhage; R A Goldbohm; P A van den Brandt
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640

10.  Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.

Authors:  Ying Gao; Gary O Rankin; Youying Tu; Yi Charlie Chen
Journal:  Int J Oncol       Date:  2015-11-20       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.